News & Updates

Modified dual therapy on par with recommended regimen in H. pylori infection
Modified dual therapy on par with recommended regimen in H. pylori infection
28 Oct 2021

A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Modified dual therapy on par with recommended regimen in H. pylori infection
28 Oct 2021
Online symptom checkers unreliable for COVID-19 triage
Online symptom checkers unreliable for COVID-19 triage
28 Oct 2021 byTristan Manalac

Though promising, coronavirus disease 2019 (COVID-19) symptom checkers—online, patient-led triage systems—are unable to reliably distinguish mild from severe COVID-19 and may instead put the public and healthcare workers at greater risk of infection, according to a recent study.

Online symptom checkers unreliable for COVID-19 triage
28 Oct 2021